Cargando…

CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis

OBJECTIVE: Anti-leucine-rich glioma inactivated 1(LGI1) encephalitis is one rare autoimmune encephalitis which is accompanied by inflammatory responses. (Anti-leucine-rich glioma inactivated 1 (anti-LGI1) encephalitis is an autoimmune disease mediated by inflammatory responses.)This study aimed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinyi, Li, Hongyan, Wang, Yunhuan, Zhao, Xiuhe, Wang, Shengjun, Li, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849687/
https://www.ncbi.nlm.nih.gov/pubmed/36685530
http://dx.doi.org/10.3389/fimmu.2022.1071219
_version_ 1784872005477072896
author Li, Jinyi
Li, Hongyan
Wang, Yunhuan
Zhao, Xiuhe
Wang, Shengjun
Li, Ling
author_facet Li, Jinyi
Li, Hongyan
Wang, Yunhuan
Zhao, Xiuhe
Wang, Shengjun
Li, Ling
author_sort Li, Jinyi
collection PubMed
description OBJECTIVE: Anti-leucine-rich glioma inactivated 1(LGI1) encephalitis is one rare autoimmune encephalitis which is accompanied by inflammatory responses. (Anti-leucine-rich glioma inactivated 1 (anti-LGI1) encephalitis is an autoimmune disease mediated by inflammatory responses.)This study aimed to investigate the Chitinase 3-like 1(CHI3L1) in anti-LGI1encephalitis patients and evaluate its association with modified Rankin Scale (mRS) score in anti-LGI1 encephalitis at admission and 6 months follow-up.(This study looked into the relationship between Chitinase 3-like 1 (CHI3L1) and the modified Ranking Scale (mRS) score in anti-LGI1 encephalitis patients at admission and 6 months later.) METHODS: Thirty-five patients with anti-LGI1 encephalitis and 22 patients with non-inflammatory neurological disease were enrolled in this study. (We enrolled 35 patients with anti-LGI1 encephalitis and 22 patients with non-inflammatory neurological disease.)Cerebrospinal fluid (CSF) and serum levels of CHI3L1 were measured by enzyme-linked immunosorbent assay. (We quantified CHI3L1 in the serum and cerebrospinal fluid (CSF) by performing an enzyme-linked immunosorbent assay.)Patients were evaluated for mRS score at admission and at 6 months follow-up.(We recorded the mRS score of the patients at admission and 6 months later.) RESULTS: CHI3L1 levels in CSF and serum were highly elevated in patients with anti-LGI1 encephalitis at admission compared those with the controls.(At admission, patients with anti-LGI1 encephalitis had elevated CHI3L1 levels in the CSF and serum.) Additionally, patients presenting with cognitive impairment had significantly higher CSF CHI3L1 levels and mRS scores than those without cognitive impairment symptoms. Patients presenting with only faciobrachial dystonic seizures at admission had lower CSF CHI3L1 levels than those with other symptoms. Finally, CSF CHI3L1 levels were positively correlated with CSF lactate levels. CONCLUSION: CHI3L1 level in CSF is correlated with the severity and prognosis of anti-LGI1 encephalitis. (CSF CHI3L1 levels are correlated with the severity and prognosis of anti-LGI1 encephalitis.)
format Online
Article
Text
id pubmed-9849687
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98496872023-01-20 CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis Li, Jinyi Li, Hongyan Wang, Yunhuan Zhao, Xiuhe Wang, Shengjun Li, Ling Front Immunol Immunology OBJECTIVE: Anti-leucine-rich glioma inactivated 1(LGI1) encephalitis is one rare autoimmune encephalitis which is accompanied by inflammatory responses. (Anti-leucine-rich glioma inactivated 1 (anti-LGI1) encephalitis is an autoimmune disease mediated by inflammatory responses.)This study aimed to investigate the Chitinase 3-like 1(CHI3L1) in anti-LGI1encephalitis patients and evaluate its association with modified Rankin Scale (mRS) score in anti-LGI1 encephalitis at admission and 6 months follow-up.(This study looked into the relationship between Chitinase 3-like 1 (CHI3L1) and the modified Ranking Scale (mRS) score in anti-LGI1 encephalitis patients at admission and 6 months later.) METHODS: Thirty-five patients with anti-LGI1 encephalitis and 22 patients with non-inflammatory neurological disease were enrolled in this study. (We enrolled 35 patients with anti-LGI1 encephalitis and 22 patients with non-inflammatory neurological disease.)Cerebrospinal fluid (CSF) and serum levels of CHI3L1 were measured by enzyme-linked immunosorbent assay. (We quantified CHI3L1 in the serum and cerebrospinal fluid (CSF) by performing an enzyme-linked immunosorbent assay.)Patients were evaluated for mRS score at admission and at 6 months follow-up.(We recorded the mRS score of the patients at admission and 6 months later.) RESULTS: CHI3L1 levels in CSF and serum were highly elevated in patients with anti-LGI1 encephalitis at admission compared those with the controls.(At admission, patients with anti-LGI1 encephalitis had elevated CHI3L1 levels in the CSF and serum.) Additionally, patients presenting with cognitive impairment had significantly higher CSF CHI3L1 levels and mRS scores than those without cognitive impairment symptoms. Patients presenting with only faciobrachial dystonic seizures at admission had lower CSF CHI3L1 levels than those with other symptoms. Finally, CSF CHI3L1 levels were positively correlated with CSF lactate levels. CONCLUSION: CHI3L1 level in CSF is correlated with the severity and prognosis of anti-LGI1 encephalitis. (CSF CHI3L1 levels are correlated with the severity and prognosis of anti-LGI1 encephalitis.) Frontiers Media S.A. 2023-01-05 /pmc/articles/PMC9849687/ /pubmed/36685530 http://dx.doi.org/10.3389/fimmu.2022.1071219 Text en Copyright © 2023 Li, Li, Wang, Zhao, Wang and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Li, Jinyi
Li, Hongyan
Wang, Yunhuan
Zhao, Xiuhe
Wang, Shengjun
Li, Ling
CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
title CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
title_full CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
title_fullStr CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
title_full_unstemmed CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
title_short CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
title_sort chi3l1 in the csf is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849687/
https://www.ncbi.nlm.nih.gov/pubmed/36685530
http://dx.doi.org/10.3389/fimmu.2022.1071219
work_keys_str_mv AT lijinyi chi3l1inthecsfisapotentialbiomarkerforantileucinerichgliomainactivated1encephalitis
AT lihongyan chi3l1inthecsfisapotentialbiomarkerforantileucinerichgliomainactivated1encephalitis
AT wangyunhuan chi3l1inthecsfisapotentialbiomarkerforantileucinerichgliomainactivated1encephalitis
AT zhaoxiuhe chi3l1inthecsfisapotentialbiomarkerforantileucinerichgliomainactivated1encephalitis
AT wangshengjun chi3l1inthecsfisapotentialbiomarkerforantileucinerichgliomainactivated1encephalitis
AT liling chi3l1inthecsfisapotentialbiomarkerforantileucinerichgliomainactivated1encephalitis